Clinical trial
A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole
NCT07199504 is registered in ClinicalTrials.gov with Yunfeng Xia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole
- Lead sponsor
- Yunfeng Xia
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- September 20, 2025
- Completion date
- December 31, 2026
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
restless leg syndrome due to uraemia